Qigong for pre & stage 1 hypertensio
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0001397
- Lead Sponsor
- Korea Institute of Oriental Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 52
1. Men and women, aged 19 to 65 years
2. Blood pressure is in the prehypertension stage or at stage 1 hypertension (systolic blood pressure of 120-159 mmHg or diastolic blood pressure of 80-99 mmHg) (by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria)
3. Provide consent to participate in this trial and sign an informed consent statement
1. Taking medicine for blood pressure control, such as prescription or over the counter drug or herb/supplements
2. Secondary hypertension
3. Previous cerebrovascular or heart disease such as myocardial infarction, angina and valvular disease
4. Wasting disease
5. Insulin or diabetes medication in diabetic patients
6. Previous kidney, liver or hyperthyroidism
7. Active tuberculosis and other infectious disease
8. Systemic steroids or immunosuppressive therapy
9. Oral contraceptives, central nervous system inhibitors or stimulants, such as taking medication that affects blood pressure
10. Pregnant women, lactating and pregnant women who plan on
11. Others whose clinical trials conductors are considered inappropriate for participating in this trial
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The average systolic blood pressure
- Secondary Outcome Measures
Name Time Method Measure Yourself Medical Outcome Profile 2 (MYMOP2);The average systolic blood pressure ;The average diastolic blood pressure ;Body mass index (BMI);Lipid profile;Adverse events;Quality of life (EuroQol-5 Dimension, EQ-5D)